All Global Research articles can be read in 27 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version).
Pfizer Inc, is currently involved in marketing its experimental mRNA vaccine with the relentless support of national governments. Amply documented, barely reported by the media, numerous cases of deaths and injury have occurred.
What is at stake is what you might call “C.Y.A”, namely.
“the bureaucratic technique of averting future accusations of policy error or wrongdoing by deflecting responsibility in advance” (William Safire, NYT,)
Extensive fraud and coverup prevail at the highest levels of government.
The “Green Light” to market the experimental mRNA vaccine was granted back in December 2020, despite the fact that according to the FDA, the vaccine is an “unapproved product”.
The FDA in its ambiguous (C.Y.O) statement has provided a so-called Emergency Use Authorization (EUA) to the Pfizer-BioNTech vaccine, namely “to permit the emergency use of the unapproved product, … for active immunization…” (see below)
There is something fishy and “contradictory” in this statement. The experimental Pfizer mRNA vaccine is both “unapproved” and “permitted”.
I have checked this statement with a prominent lawyer. It is blatantly illegal to market an “unapproved product”.
The Pfizer- Moderna vaccine is categorized by the CDC as an “investigational drug”. “The emergency use” is there to justify the launching of what might be described as an “illegal drug”. There is an ongoing fear campaign but there is no “emergency” which justifies “emergency use” Why:
- Both the WHO and the CDC have confirmed that Covid-19 is “similar to seasonal influenza” it is not a killer virus.
- The PCR test used to estimate “confirmed positive cases” is flawed.
- The Covid numbers have been hiked up.
- The validity of the test has been questioned (January 2021) by the WHO.
“Fraudulent Marketing”, “Health Care Fraud”
What is unfolding is the “fraudulent marketing” of an “unapproved” vaccine. In a historic US Department of Justice decision in September 2009,